Free silhouette oil field pump image, public domain CC0 photo.

Oil Slips as US–Iran Proposal Fuels Market Uncertainty

Oil prices declined sharply Monday, dropping over $2 amid volatile trading, as markets weighed a potential U.S.–Iran diplomatic proposal and ongoing supply concerns.

Brent crude fell 1.76% to $107.11 per barrel, while U.S. West Texas Intermediate dropped 1.82% to $109.50 in mid-session trading.

Despite the pullback, recent gains remain significant. Last week, WTI surged 11% and Brent climbed 8%, marking their strongest rally since 2020.

Analysts note that access through key shipping routes remains politically sensitive, with uncertainty continuing to drive short-term price swings.

Global refiners are actively seeking alternative crude sources, particularly from the U.S. and North Sea, as traditional supply routes face disruptions.

Shipping activity shows mixed signals, with select vessels navigating critical passages, reflecting a selective approach to maritime access policies.

Meanwhile, spot premiums for U.S. crude have surged to record highs, driven by intensifying competition between Asian and European buyers.

OPEC+ announced a modest production increase for May, though output constraints among key producers suggest limited real supply relief in the near term.

Leave a Reply

Your email address will not be published.

Previous Story

Ford US Sales Slide as Affordability Pressures Weigh on Demand

Next Story

Dimon Flags Inflation Risk as Shock Threatens Rate Outlook

Latest from Blog

Dollar Holds Firm as Markets Eye Key Developments

The U.S. dollar traded steady Monday as investors assessed rising geopolitical uncertainty and focused on negotiations surrounding a critical global shipping route. Currency markets remained cautious amid thin holiday liquidity, with traders
Go toTop

Don't Miss

Markets Waver as Oil Rises and Investors Brace for Uncertainty

Global markets showed heightened volatility Monday as rising oil prices

Neurocrine to Acquire Soleno for $2.9B, Expanding Rare Disease Portfolio

Neurocrine Biosciences announced a $2.9 billion all-cash deal to acquire